Compare Enzyme (MLN) vs Symbiosis (SIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Symbiosis — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Symbiosis trades at Rp293.08 (market cap Rp34,08M, Rp2,71M 24h volume). The key difference: Enzyme is far larger — about 3.9× Symbiosis's market cap, and Symbiosis's supply is capped (97M / 99,5M SIS (98%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Symbiosis for 12 Days on average.
| MLN | SIS | |
|---|---|---|
Market Cap | Rp134,13M | Rp34,08M |
Volume (24h) | Rp104,56M | Rp2,71M |
Circulating Supply | 3,3M MLN | 97M / 99,5M SIS (98%) |
Typical Hold Time | 28 Days | 12 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Symbiosis (SIS) shows limited market activity with a small market cap of Rp34.08M and high circulation rate of 98%. The token has nearly reached its max supply of 99.5 million tokens, with current circulating supply at 97 million. Hold time of 12 days suggests moderate trading frequency. Technical indicators show constrained trading range with low liquidity across exchanges.
Overall outlook remains cautious due to minimal market presence and liquidity concerns. Key opportunity lies in potential ecosystem growth, while major risks include extreme volatility and limited exchange support. Investors should monitor for protocol updates and increased adoption metrics.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Symbiosis
Symbiosis is a platform for cross-chain swaps that eliminates the need for multiple transactions. It aggregates liquidity from various Automated Market Makers (AMMs) and Decentralized Exchanges (DEXs) across EVM and non-EVM chains. The platform uses a decentralized Relayers Network, consisting of relayer nodes that verify and transfer information across blockchains. This network ensures secure data transfer and enhances security against central points of failure. Relayer nodes must stake SIS tokens to participate in the consensus and process swaps.
Read more on SIS →
